- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02143700
Cognitive Status in Chronic Obstructive Pulmonary Disease's Patients (COPD)
Clinical Profile and Cognitive Status in Chronic Obstructive Pulmonary Disease's Patients
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Chronic obstructive pulmonary disease is a pathology with a systemic impact with a progressive evolution that is characterized by the presence of chronic airflow obstruction.
Patients with COPD may have problems with cognitive functioning, either globally or in single cognitive domains, such as information processing, attention and concentration, memory, executive functioning and self-regulation.
Several studies have determined the prevalence of cognitive impairment in COPD compared to healthy control subjects, reaching very high levels, 36% of COPD patients with mild cognitive impairment compared with 12 % non- COPD subjects.
Tipo de estudio
Inscripción (Anticipado)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Granada, España, 18071
- Reclutamiento
- Department of Physical Therapy
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Clinical diagnosis of chronic obstructive pulmonary disease with exacerbation or stable.
- Signed written consent.
- Medical approval for inclusion
Exclusion Criteria:
- Heart disease.
- Neurological patients.
- Severe cognitive impairment in order not to complete the assessment.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Stable and exacerbated patients
Patients diagnosed of chronic obstructive pulmonary disease in a stable or exacerbated situation.
Cognitive assessment of these patients will be performed.
|
Patients are going to be assessed regarding the outcome measures
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Cognitive impairment
Periodo de tiempo: Baseline
|
The cognitive impairment will be measured using the Montreal Cognitive Assessment.
The Montreal Cognitive Assessment is a test designed as a rapid screening instrument for mild cognitive dysfunction.
It assesses different cognitive domains: attention and concentration, executive functions, memory, language, visuoconstructional skills, conceptual thinking, calculations, and orientation.
|
Baseline
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Sleep quality
Periodo de tiempo: Baseline
|
Participants are going to complete the Pittsburgh Quality of Sleep Index.
This is a self-rating questionnaire with seven subscores that result in a global score between 0 and 21.
|
Baseline
|
|
Activity monitoring
Periodo de tiempo: Baseline
|
The accelerometer Armband is going to be used for activity monitoring.
It measures the intensity of the activity during 12 hours.
|
Baseline
|
|
Nutritional state
Periodo de tiempo: Baseline
|
Mini Nutritional Assessment has been designed and validated to provide a single, rapid assessment of nutritional status in elderly patients in outpatient clinics, hospitals, and nursing homes.
It is composed of simple measurements and brief questions that can be completed in about 10 min
|
Baseline
|
|
Quality of life
Periodo de tiempo: Baseline
|
Quality of life associated with health is going to be measured with two questionnaires: the EuroQol-5 questionnaire and the Health Questionnaire St. George
|
Baseline
|
|
Cough
Periodo de tiempo: Baseline
|
The Leicester Cough Questionnaire-acute is a validated cough-related health status questionnaire designed for patients with chronic cough.
|
Baseline
|
|
Comorbidities
Periodo de tiempo: Baseline
|
Comorbidities are going to be measured with the Charlson comorbidity index.
The Charlson comorbidity index predicts the ten-year mortality for a patient who may have a range of comorbid conditions, such as heart disease, AIDS, or cancer (a total of 22 conditions).
Each condition is assigned a score of 1, 2, 3, or 6, depending on the risk of dying associated with each one.
|
Baseline
|
|
Anxiety and depression
Periodo de tiempo: Baseline
|
Patients are going to completed the Hospital Anxiety and Depression Scale composed of statements relevant to either generalized anxiety or depression.
|
Baseline
|
|
Cognitive flexibility
Periodo de tiempo: Baseline
|
The cognitive flexibility of patients is measured using the Trial Making Test.
This test explores visual-conceptual and visual-motor tracking, and it is a frequently used neuropsychological test.
|
Baseline
|
|
Forced vital capacity
Periodo de tiempo: Baseline
|
Forced vital capacity is going to be measured with a spirometer as recommended by the American Thoracic Society
|
Baseline
|
|
Forced expiratory volume in the first second
Periodo de tiempo: Baseline
|
Forced expiratory volume in the first second is going to be measured with a spirometer as recommended by the American Thoracic Society
|
Baseline
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- DF0051UG
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .